Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.2 USD | +3.95% | +5.21% | +7.05% |
22/05 | UBS Starts Colruyt Coverage With Buy Rating | MT |
22/05 | Colruyt: in the green on broker's comments | CF |
Sales 2024 * | 10.81B 11.71B 975B | Sales 2025 * | 11.49B 12.45B 1,037B | Capitalization | 5.78B 6.27B 522B |
---|---|---|---|---|---|
Net income 2024 * | 553M 599M 49.88B | Net income 2025 * | 349M 378M 31.48B | EV / Sales 2024 * | 0.56 x |
Net Debt 2024 * | 285M 309M 25.7B | Net Debt 2025 * | 338M 367M 30.52B | EV / Sales 2025 * | 0.53 x |
P/E ratio 2024 * |
6.3
x | P/E ratio 2025 * |
15.7
x | Employees | 32,000 |
Yield 2024 * |
4.94% | Yield 2025 * |
3.15% | Free-Float | 24.23% |
1 day | +3.95% | ||
1 week | +5.21% | ||
Current month | +3.51% | ||
1 month | +10.30% | ||
3 months | +10.95% | ||
6 months | +12.79% | ||
Current year | +7.05% |
Managers | Title | Age | Since |
---|---|---|---|
Stefan Goethaert
CEO | Chief Executive Officer | - | 01/12/01 |
Stefaan Vandamme
DFI | Director of Finance/CFO | - | 01/19/01 |
Jef Colruyt
CHM | Chairman | - | 01/94/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rika Coppens
BRD | Director/Board Member | 52 | 31/19/31 |
Director/Board Member | 60 | 01/11/01 | |
Jef Colruyt
CHM | Chairman | - | 01/94/01 |
Date | Price | Change | Volume |
---|---|---|---|
22/24/22 | 12.2 | +3.95% | 7,078 |
17/24/17 | 11.74 | +0.77% | 1,014 |
16/24/16 | 11.65 | +0.43% | 259 |
Delayed Quote OTC Markets, May 23, 2024 at 01:29 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.43% | 526B | |
+16.31% | 38.91B | |
+0.05% | 36.22B | |
+21.68% | 34.76B | |
+7.64% | 27.58B | |
-15.30% | 25.4B | |
+18.11% | 18.85B | |
+5.78% | 18.25B | |
+5.80% | 14.59B |
- Stock Market
- Equities
- COLR Stock
- CUYTY Stock